About PackGene Biotech INC
PackGene is a world-leading adeno-associated virus (AAV) vector CRO and CDMO company. We provide economical, reliable, and scalable plasmid DNA and AAV viral vector production for early-stage drug discovery, preclinical development and clinical trials for Cell and Gene Therapy (CGT). The proprietary π-Alpha™ 293 AAV High-yield Platform uses uniquely designed RC plasmid in the triple-plasmid transfection system to increase AAV production by 3 to 8 times. By combining in-process upstream and downstream QbD optimizations, the total AAV yield can be increased up to 10 times. A single batch of AAV production delivers up to 1E+17vg virus particles, which meets the needs of most clinical-level and commercial levels of AAV production.
PackGene is a well-known viral vector manufacturing and servicing firm among the national high-tech industries. It was founded and started up in Massachusetts, USA and is currently headquartered in Guangzhou Economic and Technological Development Zone. PackGene offers services and production of the rAAV based gene therapeutic CDMO, rAAV packaging, vector cloning, etc. And also has attracted global collaborations and financial supports.
Missions and Values
PackGene aims to Make Gene Therapy Affordable. Starting from the challenges in rAAV serotype selection, viral vector packaging and GMP production, to the stable, qualified and cost-efficient fast services and technical supports, PackGene’s goal is helping gene therapy and to make a better world. …
We are always here at your service
PackGene Biotech Co., Ltd. Guangzhou, China (HQ)
Building 3, Caipin Road, Huangpu District, Guangzhou, 510000, China.
PackGene Biotech, INC, Massachusetts, USA
9310 Kirby Dr, STE 900 Houston Texas 77054
PackGene Biotech AG, Europe
Mühlebachstrasse 43, 8008 Zürich, Switzerland